Knowledge hub

biotech US market
Blog

AI in biotech: What the US market got right (and what it’s still learning)

an Majta presenting on AI and omics data in drug discovery at NextGen Omics Conference 2025.
From Data Chaos to Drug Discovery – Ardigen Talk at NextGen Omics Conference
Foundational Models for AI in Biology
Harnessing the potential of AI in drug discovery
BioIT 2025 insights
AI, Genomics and the Future of Medicine: Highlights from Bio-IT World Conference & Expo 2025
optimization strategies for scalable bioinformatics workflows.
The Scaling Paradox: Why Adding More Cloud Resources in Bioinformatics Doesn’t Always Solve the Problem
Poster: Enabling Real-Time Analytics in Clinical Trials
Poster: Nextflow-Powered Transformation: Migrating Genomics England’s Clinical Workflows
Poster: Revolutionizing GWAS Data Exploration for Target Discovery and Drug Repurposing with LLMs and Knowledge Graphs
Poster

Poster: From Text to Genes: Can LLMs Enhance Expression Annotations?

nextgen omics 2025
Insights from NextGen Omics 2025
The role of AI CROs in the next wave of biopharma transformation)
AI CROs and the Pharma Shift: The Next Wave of Drug Discovery Innovation
AI-driven target identification process in drug discovery.
What is target identification in drug discovery?
AI for Small Molecule Drug Discovery4
AI hit-to-lead optimization for drug discovery
AI brain neurological diseases
Uncovering novel targets and approaches to treating neurological diseases
Your monthly AI in biotech digest – March
Where AI Meets Wet-Lab: A Smarter Path to Biologics Discovery Success